BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15678845)

  • 1. The coexistence of atypical intraductal hyperplasias with breast carcinoma.
    Bogdan F; Gîrniţă L; Florescu M; Simionescu C; Crăiţoiu S; Comănescu V
    Rom J Morphol Embryol; 1998; 44(1-4):65-71. PubMed ID: 15678845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
    Carder PJ; Garvican J; Haigh I; Liston JC
    Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Histopathology of the breast with reference to consultant studies. II. On the diagnosis and differential diagnosis of non-neoplastic diseases and tumors].
    Bässler R; Kronsbein H; Schneider B
    Pathologe; 1989 May; 10(3):142-59. PubMed ID: 2544866
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of papillary lesions at percutaneous breast biopsy.
    Valdes EK; Tartter PI; Genelus-Dominique E; Guilbaud DA; Rosenbaum-Smith S; Estabrook A
    Ann Surg Oncol; 2006 Apr; 13(4):480-2. PubMed ID: 16474908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double immunostaining with p63 and high-molecular-weight cytokeratins distinguishes borderline papillary lesions of the breast.
    Ichihara S; Fujimoto T; Hashimoto K; Moritani S; Hasegawa M; Yokoi T
    Pathol Int; 2007 Mar; 57(3):126-32. PubMed ID: 17295644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillary lesions of the breast.
    Ibarra JA
    Breast J; 2006; 12(3):237-51. PubMed ID: 16684322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ductoscopy-based descriptors of intraductal lesions and their histopathologic correlates.
    Rose C; Bojahr B; Grunwald S; Frese H; Jäger B; Ohlinger R
    Onkologie; 2010; 33(6):307-12. PubMed ID: 20523094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast pathology practice: most common problems in a consultation service.
    Putti TC; Pinder SE; Elston CW; Lee AH; Ellis IO
    Histopathology; 2005 Nov; 47(5):445-57. PubMed ID: 16241992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal proliferations of the breast: a review of histologic criteria for atypical intraductal hyperplasia and ductal carcinoma in situ, including apocrine and papillary lesions.
    Purcell CA; Norris HJ
    Ann Diagn Pathol; 1998 Apr; 2(2):135-45. PubMed ID: 9845731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cancer of the male breast with atypical ductal hyperplasia and contralateral gynecomastia].
    Turi V; Lucev M; D'Abrosca F; Gerosa E
    Minerva Chir; 1990 Feb; 45(3-4):203-5. PubMed ID: 2162505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision.
    Wagoner MJ; Laronga C; Acs G
    Am J Clin Pathol; 2009 Jan; 131(1):112-21. PubMed ID: 19095574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists.
    Fitzgibbons PL; Henson DE; Hutter RV
    Arch Pathol Lab Med; 1998 Dec; 122(12):1053-5. PubMed ID: 9870852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillomas of the breast. A histologic spectrum including atypical hyperplasia and carcinoma in situ.
    McKinney CD; Fechner RE
    Pathol Annu; 1995; 30 Pt 2():137-78. PubMed ID: 8570274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathology of fibroadenoma of the breast.
    Kuijper A; Mommers EC; van der Wall E; van Diest PJ
    Am J Clin Pathol; 2001 May; 115(5):736-42. PubMed ID: 11345838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology of high-risk breast lesions and ductal carcinoma in situ.
    Sewell CW
    Radiol Clin North Am; 2004 Sep; 42(5):821-30, v. PubMed ID: 15337418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image cytophotometric DNA analysis of atypical hyperplasias and intraductal carcinomas of the breast.
    Crissman JD; Visscher DW; Kubus J
    Arch Pathol Lab Med; 1990 Dec; 114(12):1249-53. PubMed ID: 2174672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of invasive breast cancer and ductal carcinoma in situ in women with atypical papillary lesions of the breast.
    Cuneo KC; Dash RC; Wilke LG; Horton JK; Koontz BF
    Breast J; 2012 Sep; 18(5):475-8. PubMed ID: 22776070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic pitfalls in mammary pathology. Case 1. In situ ductal carcinoma of low nuclear grade, with papillary, micropapillary and cribriform architecture].
    MacGrogan G
    Ann Pathol; 2009 Jun; 29(3):188-93. PubMed ID: 19619824
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
    Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillary carcinoma arising from ectopic breast tissue in an axillary lymph node.
    Walker AN; Fechner RE
    Diagn Gynecol Obstet; 1982; 4(2):141-5. PubMed ID: 6284467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.